Self-Disclosure in Healthcare Fraud Cases: When and How It Can Help
Self-disclosure can allow a healthcare provider to address improper billing, overpayments, or potentially unlawful business arrangements before the government discovers the issue independently. But reporting suspected misconduct is not a simple matter of sending a letter and returning money. The appropriate disclosure channel depends on the conduct involved, the agencies with jurisdiction, and whether the issue presents civil, administrative, or criminal exposure.
For California healthcare providers, the decision can involve several overlapping processes: the U.S. Department of Health and Human Services Office of Inspector General (OIG) Health Care Fraud Self-Disclosure Protocol, the Centers for Medicare & Medicaid Services (CMS) Voluntary Self-Referral Disclosure Protocol, California’s Medi-Cal overpayment and enforcement processes, and a newly announced federal False Claims Act self-disclosure pilot. Each has a different purpose and potential benefits. The Law Offices of Art Kalantar helps healthcare providers evaluate these options and understand the risks before making a disclosure that could affect their financial, professional, and legal interests.
What Is Self-Disclosure in a Healthcare Fraud Case?
Healthcare providers sometimes discover that their organizations have submitted improper claims, received payments they were not entitled to keep, or entered into financial arrangements that violate federal or state healthcare laws. These problems can arise from billing errors, inadequate compliance controls, improper physician compensation, kickbacks, or other conduct that creates potential liability.
Self-disclosure is the process of voluntarily reporting identified misconduct or potential violations to the appropriate government agency. Depending on the circumstances, disclosure can provide an opportunity to resolve repayment obligations, reduce certain civil or administrative penalties, and demonstrate that the provider is taking corrective action. Some programs also offer protections against particular enforcement consequences.
However, self-disclosure is not always the best response to every compliance problem. A provider who reports incomplete or inaccurate information, selects the wrong disclosure program, or fails to recognize possible criminal exposure could create additional legal problems. A disclosure also does not necessarily protect individual owners, executives, physicians, or employees from prosecution.
For California healthcare providers, understanding the differences among the federal and state disclosure processes is essential before deciding whether, when, and how to report a potential violation.
The OIG Health Care Fraud Self-Disclosure Protocol
The HHS Office of Inspector General maintains a Health Care Fraud Self-Disclosure Protocol (SDP) for individuals and entities that identify potential violations subject to OIG’s civil monetary penalty authorities. Eligible parties can include healthcare providers, suppliers, manufacturers, and other individuals or organizations potentially liable under those authorities.
The OIG protocol can address matters involving potential violations of the Anti-Kickback Statute, claims involving excluded individuals, certain improper billing practices, and other conduct that could create civil monetary penalty liability. It is intended to resolve potential civil and administrative liability within OIG’s authority, not to serve as a general reporting channel for every type of healthcare compliance problem.
A provider considering an OIG disclosure should first conduct a sufficiently thorough internal investigation to understand what happened. The submission generally needs to describe the conduct, identify the potentially violated laws, explain the relevant time period, quantify the financial impact, and provide supporting information. The provider should also explain the corrective actions taken to stop the conduct and prevent recurrence.
OIG expects a disclosing party to demonstrate a genuine willingness to resolve the matter. The conduct should have ended before submission or, in the case of certain improper arrangements, the provider should commit to terminating the arrangement within the applicable period. OIG generally expects the disclosure to address potential liability within the six-year period associated with its Civil Monetary Penalty Law authority.
Potential Benefits of an OIG Disclosure
The OIG protocol can offer meaningful advantages. A successful resolution may provide a faster and more predictable path than a government-directed investigation and administrative litigation. OIG also generally offers a lower damages multiplier for qualifying self-disclosures than it might seek in a matter it discovers independently. A resolution can include a release of OIG’s civil monetary penalty and permissive exclusion authorities for the disclosed conduct, without requiring a Corporate Integrity Agreement as part of the resolution.
These benefits are not automatic. OIG reviews the facts, the completeness of the disclosure, the provider’s cooperation, and the proposed resolution. The provider should not assume that repayment alone will resolve all potential liability.
There is also an important limitation involving criminal conduct. Under the federal coordination policy issued in October 2026, a company seeking the benefits of both the Department of Justice’s Corporate Enforcement and Voluntary Self-Disclosure Policy and OIG’s protocol for potential criminal healthcare fraud should make its initial disclosure to DOJ’s National Fraud Enforcement Division. A qualifying disclosure to that division can receive the benefits of both policies without a duplicative OIG submission. A disclosure made only to OIG generally does not qualify as a voluntary self-disclosure to DOJ for purposes of the criminal corporate enforcement policy. The OIG protocol itself is directed to civil monetary penalty matters, not criminal law violations.
The CMS Voluntary Self-Referral Disclosure Protocol
CMS administers a separate disclosure process known as the Voluntary Self-Referral Disclosure Protocol (SRDP). Unlike OIG’s broader healthcare fraud protocol, the CMS process is specifically designed for actual or potential violations of the federal physician self-referral law, commonly known as the Stark Law.
The Stark Law generally prohibits a physician from referring Medicare patients for certain designated health services to an entity with which the physician or an immediate family member has a financial relationship, unless an exception applies. The law also restricts the entity from submitting claims for services furnished through prohibited referrals.
A potential Stark Law violation can arise from compensation arrangements that do not satisfy an applicable exception, ownership interests, improper rental agreements, or failures to meet required documentation and other conditions. Even when the parties did not intend to violate the law, a financial arrangement that fails to satisfy an exception can create repayment exposure.
The CMS SRDP allows providers and suppliers to voluntarily disclose actual or potential Stark Law violations. The submission requires detailed information about the arrangement, the physicians involved, the period of noncompliance, and the financial impact. CMS provides specific forms and financial analysis worksheets, and disclosures must use the current approved materials.
One important benefit is CMS’s authority to reduce the amount due and owing for qualifying Stark Law violations. The agency evaluates the circumstances and determines an appropriate resolution. However, the SRDP does not resolve every potential healthcare fraud issue. It is not a general disclosure program for Anti-Kickback Statute violations, ordinary billing errors, or all False Claims Act exposure.
CMS also makes clear that the SRDP is intended for matters the disclosing party reasonably believes involve actual or potential Stark Law violations. Providers should therefore evaluate whether the conduct belongs in the SRDP or whether another disclosure mechanism is more appropriate.
The 2026 DOJ-HHS False Claims Act Self-Disclosure Pilot
A significant development for healthcare companies is the Healthcare False Claims Act Self-Disclosure Pilot Program announced by DOJ and HHS on October 22, 2026. This six-month initiative creates a coordinated process for resolving certain potential civil False Claims Act violations and related HHS administrative exposure.
The pilot is available to qualifying healthcare providers, suppliers, manufacturers, payors, and related entities. It is intended for potential civil False Claims Act violations that were previously unknown to the federal government. A company whose conduct is already known to the government might still receive consideration for disclosure and cooperation, but it will not qualify for the pilot’s specific resolution.
To participate, a company must provide a complete account of the relevant conduct, identify the potentially violated requirements, submit supporting documents, describe corrective actions, and provide financial information sufficient to calculate the repayment. An authorized representative must certify that the submission is truthful and complete to the best of that individual’s knowledge.
The pilot provides for repayment of between 1.25 and 1.6 times the applicable base self-disclosure repayment amount. The multiplier depends on factors such as the timing of the disclosure, the duration and scope of the conduct, senior management involvement, financial benefit, and whether the company inherited liability through a business acquisition but promptly corrected the misconduct.
In exchange for a qualifying resolution, the company receives a DOJ civil release for the disclosed potential False Claims Act violations. The program also provides that OIG will not impose an exclusion or require a Corporate Integrity Agreement as part of the resolution, and CMS will not impose civil monetary penalties or revoke the company’s provider or supplier enrollment as part of the pilot resolution. The program is not a blanket immunity from unrelated conduct or criminal liability.
The pilot is particularly important because it coordinates authorities that might otherwise require separate civil disclosures. A company that qualifies does not need to make duplicative submissions for the same conduct to the existing OIG Health Care Fraud Self-Disclosure Protocol or CMS SRDP. However, the pilot does not replace the separate CMS process for Stark Law matters that do not implicate the False Claims Act.
Submissions must be received by 11:59 p.m. on April 22, 2027. Late or incomplete submissions will not be accepted or reviewed. Because the pilot has specific eligibility and documentation requirements, providers should carefully assess whether it applies before making a submission.
California Self-Disclosure and Medi-Cal Overpayments
California healthcare providers must also consider state-level reporting and repayment obligations. The Department of Health Care Services (DHCS) oversees Medi-Cal program integrity through its Audits and Investigations Division and other units. These agencies conduct audits, investigate suspected fraud, and pursue recovery of improper Medi-Cal payments.
Unlike the federal OIG and CMS processes, California does not provide one universal provider self-disclosure protocol that resolves every type of potential Medi-Cal fraud or billing violation. The appropriate route depends on whether the provider has identified an ordinary overpayment, a potential fraud issue, or conduct that could trigger multiple state and federal enforcement authorities.
For identified Medi-Cal overpayments, DHCS’s Third Party Liability and Recovery Division operates an Overpayments Program. Providers may receive notices of overpayment or demand-for-payment letters from the fiscal intermediary or auditing organization. DHCS provides an online form for inquiries to its Overpayments Unit and identifies the applicable provider contact information. If an overpayment is not paid voluntarily, the state may pursue offsets against Medi-Cal claims, seek other payment offsets, obtain a judgment, or record liens against property.
A provider should not confuse the administrative process for addressing an identified overpayment with a voluntary disclosure of suspected fraud. When the facts suggest intentional false billing, kickbacks, double billing, or claims for services never provided, the matter can involve DHCS’s Investigations Division and potentially the California Department of Justice’s Division of Medi-Cal Fraud and Elder Abuse. DHCS explains that when it establishes a credible allegation of provider fraud, it generally must impose a temporary payment suspension unless a good-cause exception applies, and it refers the matter for potential criminal investigation.
California providers must also consider the federal requirement to report and return identified overpayments. Under Section 1128J(d) of the Social Security Act, an overpayment must be reported and returned by the later of 60 days after identification or the date a corresponding cost report is due, if applicable. The statute also provides that an overpayment retained beyond the deadline can create an obligation under the federal False Claims Act. A good-faith investigation to determine whether an overpayment exists and quantify it is important, but providers should not assume that an internal review indefinitely suspends the reporting deadline.
For Medi-Cal providers, the interaction between federal repayment rules, California program requirements, and potential fraud exposure can be complicated. Legal counsel can help determine whether the matter involves a payment correction, a reportable overpayment, or conduct requiring a more formal disclosure or response to investigators.
How to Decide Whether Self-Disclosure Is Appropriate
Voluntary disclosure can be beneficial, but it is not necessarily the right strategy in every case. Before making a submission, a provider should understand the nature of the conduct, the available evidence, the financial exposure, and whether the government already knows about the issue.
An internal investigation should establish what happened, who was involved, which claims or arrangements were affected, when the conduct began and ended, and whether the problem is ongoing. It should also determine whether the issue appears to involve negligence, a compliance failure, reckless conduct, or intentional misconduct. That distinction can affect which agency has jurisdiction and which disclosure program may apply.
Providers should also consider whether disclosure could expose individuals to criminal liability. A company may have a reason to pursue a civil resolution while an owner, executive, physician, or employee faces separate criminal exposure. The interests of the organization and its individual personnel are not always identical. Separate legal representation may be necessary to address potential conflicts.
Finally, providers should evaluate the scope of any release offered by the applicable program. A settlement with OIG, CMS, DHCS, or DOJ does not necessarily resolve every possible claim, licensing issue, contractual dispute, or criminal investigation. The written resolution and the authority of the agency involved determine what is actually settled.
The Role of a Healthcare Criminal Defense Attorney
The decision to self-disclose should be made with a clear understanding of the legal and financial consequences. An attorney experienced in healthcare fraud defense can help determine whether the facts warrant disclosure, identify the appropriate agency, and evaluate whether a civil or administrative pathway could create additional criminal exposure.
Counsel can also oversee an internal investigation, assess the reliability of billing and financial analyses, identify relevant documents, and help ensure that the submission is complete and accurate. If the matter involves potential criminal conduct, counsel can evaluate the DOJ disclosure process and coordinate the response to overlapping OIG, CMS, and state enforcement issues.
A poorly planned disclosure can create problems that might have been avoided through a more careful investigation and strategy. Conversely, delaying a required overpayment return or missing an available disclosure opportunity can increase exposure. The goal is to make an informed decision based on the actual facts, applicable deadlines, and potential consequences.
Frequently Asked Questions
Does self-disclosure eliminate healthcare fraud penalties?
No. Self-disclosure can lead to more favorable treatment under certain programs, including reduced financial resolutions or releases from specified civil and administrative authorities. It does not automatically eliminate liability or guarantee protection from criminal prosecution.
What is the difference between the OIG and CMS self-disclosure protocols?
The OIG Health Care Fraud Self-Disclosure Protocol addresses potential violations subject to OIG’s civil monetary penalty authority. The CMS Self-Referral Disclosure Protocol is specifically for actual or potential violations of the federal Stark Law. A separate 2026 DOJ-HHS pilot provides a coordinated process for certain civil False Claims Act violations and related administrative exposure.
Can a California Medi-Cal provider voluntarily disclose an overpayment?
Providers can address identified Medi-Cal overpayments through DHCS’s Overpayments Program. However, an ordinary overpayment inquiry is not necessarily a fraud self-disclosure. Potential fraud can involve separate investigative and enforcement authorities, so providers should evaluate the appropriate process before reporting.
How long does a healthcare provider have to return an identified Medicare or Medicaid overpayment?
Under the federal overpayment statute, an overpayment must be reported and returned by the later of 60 days after identification or the date a corresponding cost report is due, if applicable. The facts and applicable rules determine when an overpayment is identified and how the deadline applies.
Should I consult a healthcare defense attorney before self-disclosing?
Yes, particularly when the issue could involve allegations of intentional billing misconduct, kickbacks, false claims, or potential criminal liability. An attorney can help assess the facts, identify the correct disclosure channel, and evaluate the consequences before information is submitted to the government.
Protect Your Practice Before Making a Self-Disclosure
Self-disclosure can provide healthcare providers with an opportunity to correct compliance problems and resolve certain government claims on more favorable terms. But the process requires careful planning. Choosing between the OIG protocol, CMS’s Stark Law disclosure process, the new federal False Claims Act pilot, and California’s Medi-Cal overpayment procedures depends on the nature of the conduct and the potential consequences.
The Law Offices of Art Kalantar represents healthcare providers facing audits, fraud allegations, and federal or state prosecutions. If you have been charged with fraud and abuse in healthcare, contact the Law Offices of Art Kalantar before taking any other steps. An informed legal strategy can help protect your rights, address potential liability, and avoid unnecessary exposure.